Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that i ...

Two oral, and five poster presentations will showcase the company’s progress in developing allogenic cell therapy candidates for multiple ...

Two oral, and five poster presentations will showcase the company’s progress in developing allogenic cell therapy candidates for multiple hematological malignancies ...

Our rich research culture seeks to better understand the world we live in, and – for many – make a difference that will leave it better for future generations. We are celebrating the impact of this ...